Thermo Fisher Scientific unveils next-gen mass spectrometers at ASMS 2026
The new Orbitrap platforms combine AI-driven analytics to accelerate drug discovery and development, offering enhanced sensitivity and speed.
See the latest news and media coverage for Thermo Fisher. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences technology and services company
thermofisher.comLast updated
In short: Thermo Fisher reported strong first-quarter 2026 results, completed its $8.9 billion acquisition of Clario, and set a 7% long-term growth target.
The new Orbitrap platforms combine AI-driven analytics to accelerate drug discovery and development, offering enhanced sensitivity and speed.
Board authorized $0.47 per share dividend payable July 15, 2026 to shareholders of record June 15, 2026.
Executives outlined industry leadership, AI-driven growth, PPI operational excellence, strategic M&A and a long-term target of 7% organic revenue CAGR and low‑teens adjusted EPS growth.
The award recognizes Oncomine Comprehensive Assay Plus on Ion Torrent Genexus System for analyzing 517 cancer genes in 24 hours. It accelerates tumor insights for personalized care.
'The sale to Thermo Fisher Scientific was the single biggest full exit in private equity globally announced last year,'
Thermo Fisher Scientific announced on Feb. 3 that it has completed its acquisition of Life Technologies Corporation for $76.13 in cash per fully diluted common...
Thermo Fisher Scientific (TMO) has just paired a strong Q1 2026 earnings beat and higher full year...
Detailed price information for Thermo Fisher Scientific (TMO-N) from The Globe and Mail including charting and trades.
Track Thermo Fisher and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Thermo Fisher and other trending companies.